Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homeeditorial

      editorial

      Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
      Health

      Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis

      May 31, 2022
      PetroSun, Inc. Announces Appointment of Dr. R. G. Bailey as Chief Executive Officer
      Oil & Gas

      PetroSun, Inc. Announces Appointment of Dr. R. G. Bailey as Chief Executive Officer

      May 31, 2022
      Wellfield Reports Financial Results for the First Quarter Ended March 31, 2022
      Technology

      Wellfield Reports Financial Results for the First Quarter Ended March 31, 2022

      May 30, 2022
      « 1 … 1,359 1,360 1,361

       

      LATEST NEWS

      • Investing News MongoDB Q3 Earnings Surprise
      • Investing News HP to Cut 6,000 Jobs Amid Restructuring
      • Investing News Dell’s Q3 2026 Earnings Analysis
      • Investing News Workday Q3 Earnings Report 2026 Insights
      • Investing News Alibaba’s AI Boosts Cloud Sales

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025